ERCP在急性胆源性胰腺炎中的诊治作用  

Diagnostic and therapeutic effects of ERCP in acute biliary pancreatitis

作　　者：钟谷平 李骥 廖远行 桂冠 盛建文 谢萍 ZHONG Guping;LI Ji;LIAO Yuanxing;GUI Guan;SHENG Jianwen;XIE Ping(Department of Gastroenterology,Yichun People's Hospital in Jiangxi Province,Yichun 336000,China)

机构地区：[1]江西省宜春市人民医院消化内科,江西宜春336000

出　　处：《中国现代医生》2022年第5期45-48,共4页China Modern Doctor

基　　金：江西省卫生计生委科技计划项目(20204738)。

摘　　要：目的分析内镜逆行性胰胆管造影术(ERCP)在急性胆源性胰腺炎中的诊治作用。方法选取江西省宜春市人民医院2014年6月至2019年6月诊治的100例急性胆源性胰腺炎患者开展本次试验研究,将所有患者随机分为参照组与研究组,每组各50例。参照组给予常规临床诊治,研究组给予ERCP诊治,比较两组不同类型急性胆源性胰腺炎患者占比情况、临床症状改善情况、相关指标改善情况和不良反应发生情况。结果研究组与参照组轻症患者占比(90.00%、88.00%)和重症患者占比(10.00%、12.00%)比较,差异无统计学意义(P>0.05);与参照组腹痛缓解占比86.00%、体温恢复占比84.00%和肠道通气占比86.00%相比,研究组的98.00%、96.00%和98.00%均明显偏高(P<0.05);与参照组胆红素恢复率86.00%、白细胞恢复率82.00%、尿淀粉酶恢复率84.00%和血淀粉酶恢复率82.00%相比,研究组的98.00%、98.00%、96.00%和98.00%均明显偏高(P<0.05);与参照组不良反应总发生率(16.00%)相比,研究组(4.00%)明显偏低(P<0.05)。结论给予急性胆源性胰腺炎患者ERCP诊治可以对患者临床指标和症状进行有效改善,临床疗效显著,安全性高,具有推广价值。Objective To analyze the diagnostic and therapeutic effects of ERCP in acute biliary pancreatitis.Methods A total of 100 patients with acute biliary pancreatitis who were diagnosed and treated in Yichun People′s Hospital in Jiangxi Province June 2014 to June 2019 were selected for this study,and all patients were randomly divided into the reference group and the study group,each group had 50 cases.The reference group was given routine clinical diagnosis and treatment,and the study group was given ERCP treatment.The proportions of patients with different types of acute biliary pancreatitis,improvement of clinical symptoms,improvement of related indicators and occurrence of adverse reactions were compared between the two groups.Results The proportions of mild patients in the study group’and the refereve group were 90.00% and 88.00%,and those of severe patients were 10.00%and 12.00%,with no statistically significant differences(P>0.05).Compared with 86.00% of the abdominal pain relief rate,84.00% of the body temperature recovery rate and 86.00% of the intestinal ventilation rate in the reference group,98.00%,96.00% and 98.00% in the study group were significantly higher(P<0.05).Compared with 86.00% of the bilirubin recovery rate,82.00% of the white blood cell recovery rate,84.00% of the urinary amylase recovery rate and 82.00%of the blood amylase recovery rate in the reference group,the 98.00%,98.00%,96.00% and 98.00% in the study group were significantly higher(P<0.05).The total incidence of adverse reactions in the study group was 4.00%,which was significantly lower than16.00% in the reference group(P<0.05).Conclusion The ERCP diagnosis and treatment for patients with acute biliary pancreatitis can effectively improve the clinical indicators and symptoms of patients with significant clinical efficacy,high safety,and has the value of promotion.

关 键 词：ERCP 急性胆源性胰腺炎 不良反应 症状 胆红素 尿淀粉酶 

分 类 号：R576.5[医药卫生—消化系统]